{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:19:34Z","timestamp":1787843974996,"version":"build-2784847793"},"posted":{"date-parts":[[2026,8,27]]},"group-title":"In Review","reference-count":79,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,4,22]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <bold>Background:<\/bold>\n                  Alzheimer's disease shows prolonged prodromal stability before accelerating decline, yet molecular markers resolving this heterogeneity are limited. We asked whether astrocytic prostaglandin D2 synthase (PTGDS) marks a statistically resolved metabolic inflection during this transition.\n                  <bold>Methods:<\/bold>\n                  We analysed 1.24 million single nuclei retained after quality control from the Seattle Alzheimer's Disease Brain Cell Atlas middle temporal gyrus dataset (84 donors), ordered along a continuous pseudo-progression score, using donor-level quadratic and segmented regression with donor bootstrap resampling and leave-one-donor-out refitting. Findings were then examined in independent bulk brain proteomics (ROSMAP and Banner cohorts), in cerebrospinal fluid proteomics from the Alzheimer's Disease Neuroimaging Initiative on two orthogonal platforms, in a reversible zebrafish model of mild cognitive impairment, and in an amyloid-beta mouse model.\n                  <bold>Results:<\/bold>\n                  PTGDS followed a biphasic astrocytic trajectory with a statistically resolved donor-level inflection (quadratic term \u22122.27, p = 0.006; vertex at pseudo-progression score 0.47, bootstrap 95% confidence interval 0.32 to 0.53). The same directional change was reproduced in ROSMAP and Banner brain proteomics (Alzheimer's disease versus control p = 3.4 \u00d7 10\u22123), and the biphasic pattern reconciles previously conflicting cerebrospinal fluid reports as stage-dependent. In cerebrospinal fluid, downstream neurofilament light tracked cognitive decline strongly and lipocalin-2 weakly, whereas PTGDS itself was tissue-restricted and not a stand-alone predictor.\n                  <bold>Limitations:<\/bold>\n                  The atlas provides pseudo-time rather than longitudinal sampling, so causality is not established. Coverage is restricted to one cortical region, donor coverage across the pseudo-progression range is uneven with a single donor in the lowest bin, lipocalin-2 transcript detection was sparse, zebrafish validation covered only the early compensatory phase, and the pharmacological arm was not tested after the inflection.\n                  <bold>Conclusions:<\/bold>\n                  These data position astrocytic PTGDS as a candidate stage marker, not a causal driver, of the compensatory-to-vulnerable shift in prodromal Alzheimer's disease, with potential relevance to stage-stratified patient selection. We propose, but do not establish, that attenuation of PTGDS after the inflection accompanies lipocalin-2-linked inflammation and suppression of nerve growth factor receptor.\n                <\/p>","DOI":"10.21203\/rs.3.rs-9499795\/v3","type":"posted-content","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:41:30Z","timestamp":1787841690000},"source":"Crossref","is-referenced-by-count":0,"title":["A biphasic astrocytic PTGDS trajectory marks a metabolic vulnerability stage in prodromal Alzheimer\u2019s disease"],"prefix":"10.21203","author":[{"given":"YoungOuk","family":"Kim","sequence":"first","affiliation":[{"name":"BioXP Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WooMyung","family":"Heo","sequence":"additional","affiliation":[{"name":"BioXP Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Jin","family":"Park","sequence":"additional","affiliation":[{"name":"Kangwon National University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YoungChul","family":"Kim","sequence":"additional","affiliation":[{"name":"BioXP Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Eun","family":"Cho","sequence":"additional","affiliation":[{"name":"Kangwon National University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Won","family":"Lee","sequence":"additional","affiliation":[{"name":"Kangwon National University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JungYeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Zefit Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1212\/01.CON.0000429175.29601.97","article-title":"Mild cognitive impairment","volume":"19","author":"Lopez OL","year":"2013","unstructured":"Lopez OL (2013) Mild cognitive impairment. Continuum 19:411\u2013424. https:\/\/doi.org\/10.1212\/01.CON.0000429175.29601.97","journal-title":"Continuum"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston G","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A et al (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396:413\u2013446. https:\/\/doi.org\/10.1016\/S0140-6736(20)30367-6","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization","volume":"74","author":"Petersen RC","year":"2010","unstructured":"Petersen RC, Aisen PS, Beckett LA et al (2010) Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology 74:201\u2013209. https:\/\/doi.org\/10.1212\/WNL.0b013e3181cb3e25","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long JM","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179:312\u2013339. https:\/\/doi.org\/10.1016\/j.cell.2019.09.001","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe DJ","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med 8:595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210","journal-title":"EMBO Mol Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease","volume":"330","author":"Sims JR","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD et al (2023) Donanemab in early symptomatic Alzheimer disease. JAMA 330:512\u2013527. https:\/\/doi.org\/10.1001\/jama.2023.13239","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"Dyck CH","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P et al (2023) Lecanemab in early Alzheimer's disease. N Engl J Med 388:9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2019.01.002","article-title":"Neuroinflammation in mild cognitive impairment and Alzheimer's disease: a meta-analysis","volume":"50","author":"Bradburn S","year":"2019","unstructured":"Bradburn S, Murgatroyd C, Ray N (2019) Neuroinflammation in mild cognitive impairment and Alzheimer's disease: a meta-analysis. Ageing Res Rev 50:1\u20138. https:\/\/doi.org\/10.1016\/j.arr.2019.01.002","journal-title":"Ageing Res Rev"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer's disease: current evidence and future directions","volume":"12","author":"Calsolaro V","year":"2016","unstructured":"Calsolaro V, Edison P (2016) Neuroinflammation in Alzheimer's disease: current evidence and future directions. Alzheimers Dement 12:719\u2013732. https:\/\/doi.org\/10.1016\/j.jalz.2016.02.010","journal-title":"Alzheimers Dement"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the central nervous system during health and neurodegeneration","volume":"35","author":"Colonna M","year":"2017","unstructured":"Colonna M, Butovsky O (2017) Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol 35:441\u2013468. https:\/\/doi.org\/10.1146\/annurev-immunol-051116-052358","journal-title":"Annu Rev Immunol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41591-019-0375-9","article-title":"Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer's disease","volume":"25","author":"Moreno-Jim\u00e9nez EP","year":"2019","unstructured":"Moreno-Jim\u00e9nez EP, Flor-Garc\u00eda M, Terreros-Roncal J et al (2019) Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer's disease. Nat Med 25:554\u2013560. https:\/\/doi.org\/10.1038\/s41591-019-0375-9","journal-title":"Nat Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3390\/brainsci11101299","article-title":"Glial PAMPering and DAMPening of adult hippocampal neurogenesis","volume":"11","author":"Parkitny L","year":"2021","unstructured":"Parkitny L, Maletic-Savatic M (2021) Glial PAMPering and DAMPening of adult hippocampal neurogenesis. Brain Sci 11:1299. https:\/\/doi.org\/10.3390\/brainsci11101299","journal-title":"Brain Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack CR","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K et al (2018) NIA-AA Research Framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement 14:535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens P","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M et al (2021) Alzheimer's disease. Lancet 397:1577\u20131590. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer's disease: current status and prospects for the future","volume":"284","author":"Blennow K","year":"2018","unstructured":"Blennow K, Zetterberg H (2018) Biomarkers for Alzheimer's disease: current status and prospects for the future. J Intern Med 284:643\u2013663. https:\/\/doi.org\/10.1111\/joim.12816","journal-title":"J Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1038\/s41593-024-01774-5","article-title":"Integrated multimodal cell atlas of Alzheimer's disease","volume":"27","author":"Gabitto MI","year":"2024","unstructured":"Gabitto MI, Travaglini KJ, Rachleff VM et al (2024) Integrated multimodal cell atlas of Alzheimer's disease. Nat Neurosci 27:2366\u20132383. https:\/\/doi.org\/10.1038\/s41593-024-01774-5","journal-title":"Nat Neurosci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"101984","DOI":"10.1016\/j.arr.2023.101984","article-title":"Association between lipocalin-2 and mild cognitive impairment or dementia: a systematic review and meta-analysis","volume":"89","author":"Li X","year":"2023","unstructured":"Li X, Wang X, Guo L et al (2023) Association between lipocalin-2 and mild cognitive impairment or dementia: a systematic review and meta-analysis. Ageing Res Rev 89:101984. https:\/\/doi.org\/10.1016\/j.arr.2023.101984","journal-title":"Ageing Res Rev"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1096\/fj.11-202457","article-title":"Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease","volume":"26","author":"Naud\u00e9 PJW","year":"2012","unstructured":"Naud\u00e9 PJW, Nyakas C, Eiden LE et al (2012) Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. FASEB J 26:2811\u20132823. https:\/\/doi.org\/10.1096\/fj.11-202457","journal-title":"FASEB J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neubiorev.2014.12.006","article-title":"Diverse functional roles of lipocalin-2 in the central nervous system","volume":"49","author":"Jha MK","year":"2015","unstructured":"Jha MK, Lee S, Park DH et al (2015) Diverse functional roles of lipocalin-2 in the central nervous system. Neurosci Biobehav Rev 49:135\u2013156. https:\/\/doi.org\/10.1016\/j.neubiorev.2014.12.006","journal-title":"Neurosci Biobehav Rev"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fncel.2013.00122","article-title":"Lipocalin-2 is involved in emotional behaviors and cognitive function","volume":"7","author":"Ferreira AC","year":"2013","unstructured":"Ferreira AC, Pinto V, Mesquita SD et al (2013) Lipocalin-2 is involved in emotional behaviors and cognitive function. Front Cell Neurosci 7:122. https:\/\/doi.org\/10.3389\/fncel.2013.00122","journal-title":"Front Cell Neurosci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12974-018-1372-5","article-title":"Lipocalin 2 contributes to brain iron dysregulation but does not affect cognition, plaque load, and glial activation in the J20 Alzheimer mouse model","volume":"15","author":"Dekens DW","year":"2018","unstructured":"Dekens DW, Naud\u00e9 PJW, Keijser JN et al (2018) Lipocalin 2 contributes to brain iron dysregulation but does not affect cognition, plaque load, and glial activation in the J20 Alzheimer mouse model. J Neuroinflammation 15:330. https:\/\/doi.org\/10.1186\/s12974-018-1372-5","journal-title":"J Neuroinflammation"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41536-023-00311-5","article-title":"Nerve growth factor receptor (Ngfr) induces neurogenic plasticity by suppressing reactive astroglial Lcn2\/Slc22a17 signaling in Alzheimer's disease","volume":"8","author":"Siddiqui T","year":"2023","unstructured":"Siddiqui T, Cosacak MI, Popova S et al (2023) Nerve growth factor receptor (Ngfr) induces neurogenic plasticity by suppressing reactive astroglial Lcn2\/Slc22a17 signaling in Alzheimer's disease. npj Regen Med 8:33. https:\/\/doi.org\/10.1038\/s41536-023-00311-5","journal-title":"npj Regen Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2005.10.027","article-title":"A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake","volume":"123","author":"Devireddy LR","year":"2005","unstructured":"Devireddy LR, Gazin C, Zhu X, Green MR (2005) A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123:1293\u20131305. https:\/\/doi.org\/10.1016\/j.cell.2005.10.027","journal-title":"Cell"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1101\/gad.183434.111","article-title":"NF-\u03baB, the first quarter-century: remarkable progress and outstanding questions","volume":"26","author":"Hayden MS","year":"2012","unstructured":"Hayden MS, Ghosh S (2012) NF-\u03baB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 26:203\u2013234. https:\/\/doi.org\/10.1101\/gad.183434.111","journal-title":"Genes Dev"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu T","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2:17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23","journal-title":"Signal Transduct Target Ther"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1523\/JNEUROSCI.4531-05.2006","article-title":"Prostaglandin D2-mediated microglia\/astrocyte interaction enhances astrogliosis and demyelination in twitcher","volume":"26","author":"Mohri I","year":"2006","unstructured":"Mohri I, Taniike M, Taniguchi H et al (2006) Prostaglandin D2-mediated microglia\/astrocyte interaction enhances astrogliosis and demyelination in twitcher. J Neurosci 26:4383\u20134393. https:\/\/doi.org\/10.1523\/JNEUROSCI.4531-05.2006","journal-title":"J Neurosci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/01.jnen.0000240472.43038.27","article-title":"Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease","volume":"66","author":"Mohri I","year":"2007","unstructured":"Mohri I, Kadoyama K, Kanekiyo T et al (2007) Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease. J Neuropathol Exp Neurol 66:469\u2013480. https:\/\/doi.org\/10.1097\/01.jnen.0000240472.43038.27","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nbd.2019.04.003","article-title":"A Parkinson's disease gene, DJ-1, regulates anti-inflammatory roles of astrocytes through prostaglandin D2 synthase expression","volume":"127","author":"Choi D-J","year":"2019","unstructured":"Choi D-J, An J, Jou I et al (2019) A Parkinson's disease gene, DJ-1, regulates anti-inflammatory roles of astrocytes through prostaglandin D2 synthase expression. Neurobiol Dis 127:482\u2013491. https:\/\/doi.org\/10.1016\/j.nbd.2019.04.003","journal-title":"Neurobiol Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.1073\/pnas.0701585104","article-title":"Lipocalin-type prostaglandin D synthase\/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid","volume":"104","author":"Kanekiyo T","year":"2007","unstructured":"Kanekiyo T, Ban T, Aritake K et al (2007) Lipocalin-type prostaglandin D synthase\/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid. Proc Natl Acad Sci USA 104:6412\u20136417. https:\/\/doi.org\/10.1073\/pnas.0701585104","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"eaaz9360","DOI":"10.1126\/sciadv.aaz9360","article-title":"Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease","volume":"6","author":"Higginbotham L","year":"2020","unstructured":"Higginbotham L, Ping L, Dammer EB et al (2020) Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease. Sci Adv 6:eaaz9360. https:\/\/doi.org\/10.1126\/sciadv.aaz9360","journal-title":"Sci Adv"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","article-title":"Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation","volume":"26","author":"Johnson ECB","year":"2020","unstructured":"Johnson ECB, Dammer EB, Duong DM et al (2020) Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med 26:769\u2013780. https:\/\/doi.org\/10.1038\/s41591-020-0815-6","journal-title":"Nat Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"718002","DOI":"10.3389\/fphys.2021.718002","article-title":"Biochemical and structural characteristics, gene regulation, physiological, pathological and clinical features of lipocalin-type prostaglandin D2 synthase as a multifunctional lipocalin","volume":"12","author":"Urade Y","year":"2021","unstructured":"Urade Y (2021) Biochemical and structural characteristics, gene regulation, physiological, pathological and clinical features of lipocalin-type prostaglandin D2 synthase as a multifunctional lipocalin. Front Physiol 12:718002. https:\/\/doi.org\/10.3389\/fphys.2021.718002","journal-title":"Front Physiol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","article-title":"Scrublet: computational identification of cell doublets in single-cell transcriptomic data","volume":"8","author":"Wolock SL","year":"2019","unstructured":"Wolock SL, Lopez R, Klein AM (2019) Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst 8:281\u2013291. https:\/\/doi.org\/10.1016\/j.cels.2018.11.005","journal-title":"Cell Syst"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.3390\/math11244959","article-title":"An advanced segmentation approach to piecewise regression models","volume":"11","author":"Lu K-P","year":"2023","unstructured":"Lu K-P, Chang S-T (2023) An advanced segmentation approach to piecewise regression models. Mathematics 11:4959. https:\/\/doi.org\/10.3390\/math11244959","journal-title":"Mathematics"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin S","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L et al (2021) Inference and analysis of cell-cell communication using CellChat. Nat Commun 12:1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9","journal-title":"Nat Commun"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: single-cell regulatory network inference and clustering","volume":"14","author":"Aibar S","year":"2017","unstructured":"Aibar S, Bravo Gonz\u00e1lez-Blas C, Moerman T et al (2017) SCENIC: single-cell regulatory network inference and clustering. Nat Methods 14:1083\u20131086. https:\/\/doi.org\/10.1038\/nmeth.4463","journal-title":"Nat Methods"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature12111","article-title":"The zebrafish reference genome sequence and its relationship to the human genome","volume":"496","author":"Howe K","year":"2013","unstructured":"Howe K, Clark MD, Torroja CF et al (2013) The zebrafish reference genome sequence and its relationship to the human genome. Nature 496:498\u2013503. https:\/\/doi.org\/10.1038\/nature12111","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.expneurol.2017.10.004","article-title":"The developing utility of zebrafish models of neurological and neuropsychiatric disorders: a critical review","volume":"299","author":"Fontana BD","year":"2018","unstructured":"Fontana BD, Mezzomo NJ, Kalueff AV, Rosemberg DB (2018) The developing utility of zebrafish models of neurological and neuropsychiatric disorders: a critical review. Exp Neurol 299:157\u2013171. https:\/\/doi.org\/10.1016\/j.expneurol.2017.10.004","journal-title":"Exp Neurol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s10522-019-09837-y","article-title":"D-galactose-induced accelerated aging model: an overview","volume":"20","author":"Azman KF","year":"2019","unstructured":"Azman KF, Zakaria R (2019) D-galactose-induced accelerated aging model: an overview. Biogerontology 20:763\u2013782. https:\/\/doi.org\/10.1007\/s10522-019-09837-y","journal-title":"Biogerontology"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fcell.2018.00135","article-title":"Zebrafish \u2014 a model organism for studying the neurobiological mechanisms underlying cognitive brain aging and use of potential interventions","volume":"6","author":"Adams MM","year":"2018","unstructured":"Adams MM, Kafaligonul H (2018) Zebrafish \u2014 a model organism for studying the neurobiological mechanisms underlying cognitive brain aging and use of potential interventions. Front Cell Dev Biol 6:135. https:\/\/doi.org\/10.3389\/fcell.2018.00135","journal-title":"Front Cell Dev Biol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1515\/RNS.2011.008","article-title":"Imaging escape and avoidance behavior in zebrafish larvae","volume":"22","author":"Colwill RM","year":"2011","unstructured":"Colwill RM, Creton R (2011) Imaging escape and avoidance behavior in zebrafish larvae. Rev Neurosci 22:63\u201373. https:\/\/doi.org\/10.1515\/RNS.2011.008","journal-title":"Rev Neurosci"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbr.2011.04.033","article-title":"A novel high-throughput imaging system for automated analyses of avoidance behavior in zebrafish larvae","volume":"223","author":"Pelkowski SD","year":"2011","unstructured":"Pelkowski SD, Kapoor M, Richendrfer HA et al (2011) A novel high-throughput imaging system for automated analyses of avoidance behavior in zebrafish larvae. Behav Brain Res 223:135\u2013144. https:\/\/doi.org\/10.1016\/j.bbr.2011.04.033","journal-title":"Behav Brain Res"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.gene.2006.01.037","article-title":"Zebrafish and chicken lipocalin-type prostaglandin D synthase homologues: conservation of mammalian gene structure and binding ability for lipophilic molecules","volume":"375","author":"Fujimori K","year":"2006","unstructured":"Fujimori K, Inui T, Uodome N et al (2006) Zebrafish and chicken lipocalin-type prostaglandin D synthase homologues: conservation of mammalian gene structure and binding ability for lipophilic molecules. Gene 375:14\u201325. https:\/\/doi.org\/10.1016\/j.gene.2006.01.037","journal-title":"Gene"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1186\/s12864-016-2981-y","article-title":"Phylogenetic, syntenic, and tissue expression analysis of slc22 genes in zebrafish (Danio rerio)","volume":"17","author":"Mihaljevic I","year":"2016","unstructured":"Mihaljevic I, Popovic M, Zaja R, Smital T (2016) Phylogenetic, syntenic, and tissue expression analysis of slc22 genes in zebrafish (Danio rerio). BMC Genomics 17:626. https:\/\/doi.org\/10.1186\/s12864-016-2981-y","journal-title":"BMC Genomics"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.pharmthera.2011.01.010","article-title":"Therapeutic applications of compounds in the Magnolia family","volume":"130","author":"Lee Y-J","year":"2011","unstructured":"Lee Y-J, Lee YM, Lee C-K et al (2011) Therapeutic applications of compounds in the Magnolia family. Pharmacol Ther 130:157\u2013176. https:\/\/doi.org\/10.1016\/j.pharmthera.2011.01.010","journal-title":"Pharmacol Ther"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"6849","DOI":"10.2147\/DDDT.S528831","article-title":"Wedelolactone ameliorates ischemic stroke by inhibiting oxidative damage and ferroptosis via HIF-1\u03b1\/SLC7A11\/GPX4 signaling","volume":"19","author":"Tao X","year":"2025","unstructured":"Tao X, Zhao M, Gao K et al (2025) Wedelolactone ameliorates ischemic stroke by inhibiting oxidative damage and ferroptosis via HIF-1\u03b1\/SLC7A11\/GPX4 signaling. Drug Des Devel Ther 19:6849\u20136868. https:\/\/doi.org\/10.2147\/DDDT.S528831","journal-title":"Drug Des Devel Ther"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"577319","DOI":"10.3389\/fphar.2020.577319","article-title":"Natural potent NAAA inhibitor atractylodin counteracts LPS-induced microglial activation","volume":"11","author":"Yang L","year":"2020","unstructured":"Yang L, Ji C, Li Y et al (2020) Natural potent NAAA inhibitor atractylodin counteracts LPS-induced microglial activation. Front Pharmacol 11:577319. https:\/\/doi.org\/10.3389\/fphar.2020.577319","journal-title":"Front Pharmacol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","article-title":"The Y-maze for assessment of spatial working and reference memory in mice","volume":"1916","author":"Kraeuter A-K","year":"2019","unstructured":"Kraeuter A-K, Guest PC, Sarnyai Z (2019) The Y-maze for assessment of spatial working and reference memory in mice. Methods Mol Biol 1916:105\u2013111. https:\/\/doi.org\/10.1007\/978-1-4939-8994-2_10","journal-title":"Methods Mol Biol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"a006338","DOI":"10.1101\/cshperspect.a006338","article-title":"Neurotoxicity of amyloid \u03b2-protein: synaptic and network dysfunction","volume":"2","author":"Mucke L","year":"2012","unstructured":"Mucke L, Selkoe DJ (2012) Neurotoxicity of amyloid \u03b2-protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med 2:a006338. https:\/\/doi.org\/10.1101\/cshperspect.a006338","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina A","year":"2019","unstructured":"Daina A, Michielin O, Zoete V (2019) SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47:W357\u2013W364. https:\/\/doi.org\/10.1093\/nar\/gkz382","journal-title":"Nucleic Acids Res"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkx374","article-title":"PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database","volume":"45","author":"Wang X","year":"2017","unstructured":"Wang X, Shen Y, Wang S et al (2017) PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res 45:W356\u2013W360. https:\/\/doi.org\/10.1093\/nar\/gkx374","journal-title":"Nucleic Acids Res"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"D845","DOI":"10.1093\/nar\/gkz1021","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero J","year":"2020","unstructured":"Pi\u00f1ero J, Ram\u00edrez-Anguita JM, Sa\u00fcch-Pitarch J et al (2020) The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res 48:D845\u2013D855. https:\/\/doi.org\/10.1093\/nar\/gkz1021","journal-title":"Nucleic Acids Res"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"D789","DOI":"10.1093\/nar\/gku1205","article-title":"OMIM.org: Online Mendelian Inheritance in Man, an online catalog of human genes and genetic disorders","volume":"43","author":"Amberger JS","year":"2015","unstructured":"Amberger JS, Bocchini CA, Schiettecatte F et al (2015) OMIM.org: Online Mendelian Inheritance in Man, an online catalog of human genes and genetic disorders. Nucleic Acids Res 43:D789\u2013D798. https:\/\/doi.org\/10.1093\/nar\/gku1205","journal-title":"Nucleic Acids Res"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/cpbi.5","author":"Stelzer G","year":"2016","unstructured":"Stelzer G, Rosen N, Plaschkes I et al (2016) The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics 55:1.30.1\u20131.30.33. https:\/\/doi.org\/10.1002\/cpbi.5"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk D","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M et al (2023) The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51:D638\u2013D646. https:\/\/doi.org\/10.1093\/nar\/gkac1000","journal-title":"Nucleic Acids Res"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon P","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498\u20132504. https:\/\/doi.org\/10.1101\/gr.1239303","journal-title":"Genome Res"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou Y","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L et al (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10:1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6","journal-title":"Nat Commun"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt J","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S (2021) AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings. J Chem Inf Model 61:3891\u20133898. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203","journal-title":"J Chem Inf Model"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson WE","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8:118\u2013127. https:\/\/doi.org\/10.1093\/biostatistics\/kxj037","journal-title":"Biostatistics"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2307\/2683591","article-title":"LOWESS: a program for smoothing scatter plots by robust locally weighted regression","volume":"35","author":"Cleveland WS","year":"1981","unstructured":"Cleveland WS (1981) LOWESS: a program for smoothing scatter plots by robust locally weighted regression. Am Stat 35:54. https:\/\/doi.org\/10.2307\/2683591","journal-title":"Am Stat"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu C-C","year":"2013","unstructured":"Liu C-C, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106\u2013118. https:\/\/doi.org\/10.1038\/nrneurol.2012.263","journal-title":"Nat Rev Neurol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates D","year":"2015","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S (2015) Fitting linear mixed-effects models using lme4. J Stat Softw 67:1\u201348. https:\/\/doi.org\/10.18637\/jss.v067.i01","journal-title":"J Stat Softw"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan EL","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox DR","year":"1972","unstructured":"Cox DR (1972) Regression models and life-tables. J R Stat Soc B 34:187\u2013202","journal-title":"J R Stat Soc B"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini Y","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57:289\u2013300","journal-title":"J R Stat Soc B"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13041-019-0430-y","article-title":"Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer's disease","volume":"12","author":"Adav SS","year":"2019","unstructured":"Adav SS, Park JE, Sze SK (2019) Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer's disease. Mol Brain 12:8. https:\/\/doi.org\/10.1186\/s13041-019-0430-y","journal-title":"Mol Brain"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances","volume":"15","author":"Wang X","year":"2020","unstructured":"Wang X, Zhang Z (2020) Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances. Mol Neurodegener 15:30. https:\/\/doi.org\/10.1186\/s13024-020-00376-6","journal-title":"Mol Neurodegener"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.biocel.2007.06.010","article-title":"The p75 neurotrophin receptor","volume":"40","author":"Underwood CK","year":"2008","unstructured":"Underwood CK, Coulson EJ (2008) The p75 neurotrophin receptor. Int J Biochem Cell Biol 40:1664\u20131668. https:\/\/doi.org\/10.1016\/j.biocel.2007.06.010","journal-title":"Int J Biochem Cell Biol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.phcgj.2013.08.004","article-title":"Honokiol reverses depressive-like behavior and decrease in brain BDNF levels induced by chronic corticosterone injections in mice","volume":"5","author":"Pitta S","year":"2013","unstructured":"Pitta S, Augustine BB, Kasala ER, Sulakhiya K, Ravindranath V, Lahkar M (2013) Honokiol reverses depressive-like behavior and decrease in brain BDNF levels induced by chronic corticosterone injections in mice. Pharmacognosy J 5:211\u2013215. https:\/\/doi.org\/10.1016\/j.phcgj.2013.08.004","journal-title":"Pharmacognosy J"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1093\/brain\/awx272","article-title":"Epigenetic editing of the Dlg4\/PSD95 gene improves cognition in aged and Alzheimer's disease mice","volume":"140","author":"Bustos FJ","year":"2017","unstructured":"Bustos FJ, Ampuero E, Jury N, Aguilar R, Falahi F, Toledo J, Ahumada J, Lata J, Cubillos P, Henr\u00edquez B, Guerra MV, Stehberg J, Neve RL, Inestrosa NC, Wyneken U, Fuenzalida M, H\u00e4rtel S, Sena-Esteves M, Varela-Nallar L, Rots MG, Montecino M, van Zundert B (2017) Epigenetic editing of the Dlg4\/PSD95 gene improves cognition in aged and Alzheimer's disease mice. Brain 140:3252\u20133268. https:\/\/doi.org\/10.1093\/brain\/awx272","journal-title":"Brain"},{"key":"ref71","first-page":"189","article-title":"Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein MF","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/s43587-023-00424-y","article-title":"Human microglia show unique transcriptional changes in Alzheimer's disease","volume":"3","author":"Prater KE","year":"2023","unstructured":"Prater KE, Green KJ, Mamde S et al (2023) Human microglia show unique transcriptional changes in Alzheimer's disease. Nat Aging 3:894\u2013907. https:\/\/doi.org\/10.1038\/s43587-023-00424-y","journal-title":"Nat Aging"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrn.2018.19","article-title":"Lactate in the brain: from metabolic end-product to signalling molecule","volume":"19","author":"Magistretti PJ","year":"2018","unstructured":"Magistretti PJ, Allaman I (2018) Lactate in the brain: from metabolic end-product to signalling molecule. Nat Rev Neurosci 19:235\u2013249. https:\/\/doi.org\/10.1038\/nrn.2018.19","journal-title":"Nat Rev Neurosci"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1126\/science.1225244","article-title":"Anticipating critical transitions","volume":"338","author":"Scheffer M","year":"2012","unstructured":"Scheffer M, Carpenter SR, Lenton TM et al (2012) Anticipating critical transitions. Science 338:344\u2013348. https:\/\/doi.org\/10.1126\/science.1225244","journal-title":"Science"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke J","year":"2006","unstructured":"Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7:589\u2013600. https:\/\/doi.org\/10.1038\/nrm1983","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s12035-017-0435-4","article-title":"Physiological and pathological roles of 15-deoxy-delta12,14-prostaglandin J2 in the central nervous system and neurological diseases","volume":"55","author":"Yagami T","year":"2018","unstructured":"Yagami T, Yamamoto Y, Koma H (2018) Physiological and pathological roles of 15-deoxy-delta12,14-prostaglandin J2 in the central nervous system and neurological diseases. Mol Neurobiol 55:2227\u20132248. https:\/\/doi.org\/10.1007\/s12035-017-0435-4","journal-title":"Mol Neurobiol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.clim.2004.09.008","article-title":"15d-PGJ2: the anti-inflammatory prostaglandin?","volume":"114","author":"Scher JU","year":"2005","unstructured":"Scher JU, Pillinger MH (2005) 15d-PGJ2: the anti-inflammatory prostaglandin? Clin Immunol 114:100\u2013109. https:\/\/doi.org\/10.1016\/j.clim.2004.09.008","journal-title":"Clin Immunol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1673315","DOI":"10.3389\/fnins.2025.1673315","article-title":"Ferroptosis in Alzheimer's disease: molecular mechanisms and advances in therapeutic strategies","volume":"19","author":"Zhou Z","year":"2025","unstructured":"Zhou Z, Zhang Y, Liu S et al (2025) Ferroptosis in Alzheimer's disease: molecular mechanisms and advances in therapeutic strategies. Front Neurosci 19:1673315. https:\/\/doi.org\/10.3389\/fnins.2025.1673315","journal-title":"Front Neurosci"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"101494","DOI":"10.1016\/j.redox.2020.101494","article-title":"Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine\/glutamate antiporter in Alzheimer's disease: evidence of ferroptosis","volume":"32","author":"Ashraf A","year":"2020","unstructured":"Ashraf A, Jeandriens J, Parkes HG, So P-W (2020) Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine\/glutamate antiporter in Alzheimer's disease: evidence of ferroptosis. Redox Biol 32:101494. https:\/\/doi.org\/10.1016\/j.redox.2020.101494","journal-title":"Redox Biol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9499795\/v3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9499795\/v3.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:41:32Z","timestamp":1787841692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9499795\/v3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":79,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9499795\/v3","relation":{"is-version-of":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9499795\/v1","asserted-by":"subject"},{"id-type":"doi","id":"10.21203\/rs.3.rs-9499795\/v2","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2026,8,27]]},"subtype":"preprint"}}